Page last updated: 2024-08-23

s-adenosylmethionine and Grippe

s-adenosylmethionine has been researched along with Grippe in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Carbone, J; Castro-Pearson, S; Griffin, TJ; Kan, V; Koulouris, N; Neaton, JD; Pett, S; Proper, J; Reilly, C; Wendt, CH1
Chan, AY; Fong, NC; Kwong, NS; Lai, CK; Lam, CW; Lam, DS; Law, CY; Lee, HC; Mak, CM; Ng, HL; Poon, WT; Que, TL; Siu, TS; Siu, WK; Tam, S; Tong, SF; Yuen, YP1
Alexandrova, A; Dimitrova, A; Galabov, A; Georgieva, A; Krastev, D; Mileva, M; Tsvetanova, E1

Trials

1 trial(s) available for s-adenosylmethionine and Grippe

ArticleYear
Metabolite profiles associated with disease progression in influenza infection.
    PloS one, 2021, Volume: 16, Issue:4

    Topics: Adult; Carnitine; Case-Control Studies; Disease Progression; Female; Glycerides; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Metabolome; Middle Aged; Sphingolipids

2021

Other Studies

2 other study(ies) available for s-adenosylmethionine and Grippe

ArticleYear
Fatal viral infection-associated encephalopathy in two Chinese boys: a genetically determined risk factor of thermolabile carnitine palmitoyltransferase II variants.
    Journal of human genetics, 2011, Volume: 56, Issue:8

    Topics: Amino Acid Substitution; Base Sequence; Carnitine; Carnitine O-Palmitoyltransferase; Child, Preschool; DNA Mutational Analysis; Encephalitis, Viral; Enzyme Stability; Family Health; Fatal Outcome; Female; Genetic Predisposition to Disease; Genotype; Humans; Influenza, Human; Male; Molecular Sequence Data; Mutation; Pedigree; Risk Factors; Temperature

2011
Oseltamivir and S-Adenosyl-L-Methionine Combination as Effective Therapeutic Strategy for Suppression of Oxidative Damage in Lung Caused by Influenza Virus Infection in Mice.
    Drug research, 2020, Volume: 70, Issue:6

    Topics: Animals; Antioxidants; Antiviral Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Lung; Male; Mice; Mice, Inbred BALB C; Oseltamivir; Oxidative Stress; S-Adenosylmethionine; Virus Replication

2020